Literature DB >> 28362412

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation.

Todd J Jensen1, Christopher Foster2, Wael Sayej3, Christine M Finck4.   

Abstract

Identifying and expanding patient-specific cells in culture for use in tissue engineering and disease investigation can be very challenging. Utilizing various types of stem cells to derive cell types of interest is often costly, time consuming and highly inefficient. Furthermore, undesired cell types must be removed prior to using this cell source, which requires another step in the process. In order to obtain enough esophageal epithelial cells to engineer the lumen of an esophageal construct or to screen therapeutic approaches for treating esophageal disease, native esophageal epithelial cells must be expanded without altering their gene expression or phenotype. Conditional reprogramming of esophageal epithelial tissue offers a promising approach to expanding patient-specific esophageal epithelial cells. Furthermore, these cells do not need to be sorted or purified and will return to a mature epithelial state after removing them from conditional reprogramming culture. This technique has been described in many cancer screening studies and allows for indefinite expansion of these cells over multiple passages. The ability to perform esophageal screening assays would help revolutionize the treatment of pediatric esophageal diseases like eosinophilic esophagitis by identifying the trigger mechanism causing the patient's symptoms. For those patients who suffer from congenital defect, disease or injury of the esophagus, this cell source could be used as a means to seed a synthetic construct for implantation to repair or replace the affected region.

Entities:  

Mesh:

Year:  2017        PMID: 28362412      PMCID: PMC5408910          DOI: 10.3791/55243

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  25 in total

1.  Isolation and culture of human alveolar epithelial cells.

Authors:  Carsten Ehrhardt; Kwang-Jin Kim; Claus-Michael Lehr
Journal:  Methods Mol Med       Date:  2005

2.  Culture of ovine esophageal epithelial cells and in vitro esophagus tissue engineering.

Authors:  Amulya K Saxena; Herwig Ainoedhofer; Michael E Höllwarth
Journal:  Tissue Eng Part C Methods       Date:  2010-02       Impact factor: 3.056

3.  Significance of Mouse Models in Dissecting the Mechanism of Human Eosinophilic Gastrointestinal Diseases (EGID).

Authors:  Anil Mishra
Journal:  J Gastroenterol Hepatol Res       Date:  2013

4.  Normal human urothelial cells in vitro: proliferation and induction of stratification.

Authors:  J Southgate; K A Hutton; D F Thomas; L K Trejdosiewicz
Journal:  Lab Invest       Date:  1994-10       Impact factor: 5.662

Review 5.  Incidence and prevalence of eosinophilic esophagitis in children.

Authors:  Ing S Soon; J Decker Butzner; Gilaad G Kaplan; Jennifer C C deBruyn
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-07       Impact factor: 2.839

6.  Human iPS cell-derived alveolar epithelium repopulates lung extracellular matrix.

Authors:  Mahboobe Ghaedi; Elizabeth A Calle; Julio J Mendez; Ashley L Gard; Jenna Balestrini; Adam Booth; Peter F Bove; Liqiong Gui; Eric S White; Laura E Niklason
Journal:  J Clin Invest       Date:  2013-10-25       Impact factor: 14.808

7.  Guidelines for the use of cell lines in biomedical research.

Authors:  R J Geraghty; A Capes-Davis; J M Davis; J Downward; R I Freshney; I Knezevic; R Lovell-Badge; J R W Masters; J Meredith; G N Stacey; P Thraves; M Vias
Journal:  Br J Cancer       Date:  2014-08-12       Impact factor: 7.640

8.  Comparison of methods for the isolation of human breast epithelial and myoepithelial cells.

Authors:  Arantzazu Zubeldia-Plazaola; Elisabet Ametller; Mario Mancino; Miquel Prats de Puig; Anna López-Plana; Flavia Guzman; Laia Vinyals; Eva M Pastor-Arroyo; Vanessa Almendro; Gemma Fuster; Pedro Gascón
Journal:  Front Cell Dev Biol       Date:  2015-05-21

9.  Experimental orthotopic transplantation of a tissue-engineered oesophagus in rats.

Authors:  Sebastian Sjöqvist; Philipp Jungebluth; Mei Ling Lim; Johannes C Haag; Ylva Gustafsson; Greg Lemon; Silvia Baiguera; Miguel Angel Burguillos; Costantino Del Gaudio; Antonio Beltrán Rodríguez; Alexander Sotnichenko; Karolina Kublickiene; Henrik Ullman; Heike Kielstein; Peter Damberg; Alessandra Bianco; Rainer Heuchel; Ying Zhao; Domenico Ribatti; Cristián Ibarra; Bertrand Joseph; Doris A Taylor; Paolo Macchiarini
Journal:  Nat Commun       Date:  2014-04-15       Impact factor: 14.919

10.  A cost-effective system for differentiation of intestinal epithelium from human induced pluripotent stem cells.

Authors:  Soichiro Ogaki; Mayu Morooka; Kaito Otera; Shoen Kume
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

View more
  4 in total

Review 1.  Conditionally Reprogrammed Human Normal Airway Epithelial Cells at ALI: A Physiological Model for Emerging Viruses.

Authors:  Xuefeng Liu; Yuntao Wu; Lijun Rong
Journal:  Virol Sin       Date:  2020-06-17       Impact factor: 4.327

Review 2.  Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.

Authors:  Xuefeng Liu; Abdul M Mondal
Journal:  J Med Virol       Date:  2020-06-16       Impact factor: 2.327

Review 3.  Conditional Cell Reprogramming in Modeling Digestive System Diseases.

Authors:  Ruihua Zhao; Rui Li; Tianqi An; Xuefeng Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-03

Review 4.  Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks.

Authors:  Nancy Palechor-Ceron; Ewa Krawczyk; Aleksandra Dakic; Vera Simic; Hang Yuan; Jan Blancato; Weisheng Wang; Fleesie Hubbard; Yun-Ling Zheng; Hancai Dan; Scott Strome; Kevin Cullen; Bruce Davidson; John F Deeken; Sujata Choudhury; Peter H Ahn; Seema Agarwal; Xuexun Zhou; Richard Schlegel; Priscilla A Furth; Chong-Xian Pan; Xuefeng Liu
Journal:  Cells       Date:  2019-10-27       Impact factor: 7.666

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.